Background This study aimed to determine the prevalence and predictors of working-age individuals who did not follow-up for possible hypertension that was detected in the population-based screening.
Introduction
Hypertension is one of the most common chronic diseases in the world, particularly in developed countries. In 2000, its prevalence was estimated to be at 26% for adults. 1 The United States Preventive Services Task Force recommended screening for high blood pressure (BP) in 1996, 2 but the Centers for Disease Control and Prevention recently reported that 55% of adults with uncontrolled hypertension were either unaware or aware but did not receive pharmacological treatment. 3 Forty million individuals in Japan, approximately more than one-third of the population, are estimated to have hypertension. 4 The disease and related complications account for Japanese 5.4 trillion yen (US 7.1 billion dollars) in total national medical costs. 5 Thus, secondary prevention of hypertension might have substantial merits from the clinical and societal perspectives, especially in working-age populations in whom organ damages due to hypertension can be still reversible. 6 Since the Health and Medical Service Act for the Aged was enacted in 1983, a population-based strategy to prevent and manage hypertension and to eventually prevent cardiovascular diseases, including community or workplace screening, has been implemented. 7 Once BP higher than a predetermined cutoff is considered to be possible hypertensive, identified individuals are recommended to seek medical advice and physicians give them advice or medical treatment based on further evaluations. Full transition of participants from screening to medical consultation is necessary to achieve effective results, but the prevalence of susceptible individuals who fail to follow-up is unknown.
The purpose of this study was to determine the prevalence and predictors of Japanese working-age individuals screened as possible hypertensives who did not follow-up with physicians. We particularly investigated whether the underlying diabetes mellitus, dyslipidemia, abnormal checkup data or depression would predispose the individuals to the follow-up with physicians on detected high BP.
Methods

Study population
We conducted a retrospective cohort study of individuals identified as possible hypertensives in at least one health checkup. Participants were selected from an administrative database of health insurance claims ( January 2005 through March 2011) and health checkups (March 2005 through March 2010) from Japan Medical Data Center Co., Ltd. (Tokyo, Japan). The database contained 530 000 cumulative insured individuals, mainly company employees and their family members, who were mostly from working-age populations. 8 Briefly, the database provides encrypted personal identifiers, individual demographics and insurance information, prescribed drugs in Anatomical Therapeutic Chemical (ATC) codes, 9 diagnoses coded by the International Classification of Diseases, 10th revision (ICD-10) 10 and data as of the last health checkup. This study was approved by the Ethics Committee at Kyoto University Graduate School of Medicine (E1017).
Design overview
The Japanese Society of Hypertension Guidelines for the Management of Hypertension 2009 ( JSH-2009) recommended the following method of BP measurement, which is generally used in health checkups: first, the person is placed in a quiet room to sit for several minutes; next, a BP cuff is placed at heart level to measure BP at least twice every 1 -2 min; and finally, the stable values are averaged to define BP. 7 We adopted the cutoff value to screen possible hypertension as systolic blood pressure (SBP) 140 mmHg and/or diastolic blood pressure (DBP) 90 mmHg. 11, 12 Participants fulfilling all the following criteria were included: (i) aged 20 years; (ii) possible hypertension was identified in at least one health checkup and (iii) had health insurance claim data before the checkup when possible hypertension was identified. Exclusion criteria were as follows: (i) ATC codes suggesting prescribed antihypertensive medications (C01, C03, C04, C07, C08, C09) within 3 months before high BP was identified or (ii) did not receive health checkups.
Study outcomes
We focused on the last checkup when possible hypertension was identified. The primary outcome was set as no physician follow-up for possible hypertension within 6 months of the checkup; ICD-10 codes suggesting hypertension (I10 -I15) were not generated during this period. We selected this time point, because not a few participants might presumably have checkups twice a year.
Explanatory variables
The following data were extracted from the database as of the last relevant checkup: sex, date of birth, ATC codes corresponding to prescribed antihyperglycemic (A10), antilipidemic (C10) and antidepressive agents (N06A) and ICD-10 codes corresponding to hypertension or suspected hypertension, BP values, body mass index (BMI; kg/m 2 ), hemoglobin A1c (HbA1c; %), high-density lipoprotein (HDL; mg/mL), low-density lipoprotein (LDL; mg/mL), proteinuria ( positive or negative), smoking habits (current or not), drinking habits (daily, occasionally or rarely) and number of times high BP was identified in health checkups. Age was determined by subtracting the date of birth from the last relevant checkup. Incident case was defined when high BP was identified for the first time in a certain individual. Based on JSH-2009 guidelines, hypertension was categorized as follows: Class I, SBP 140 -159 mmHg and/or DBP 90-99 mmHg; Class II, SBP 160 -179 mmHg and/or DBP 100 -109 mmHg and Class III, SBP 180 mmHg and/or DBP 110 mmHg. 7 Participants were identified as having underlying diabetes mellitus, dyslipidemia or depression when the corresponding ATC codes were generated within 3 months of the relevant checkup. HbA1c values, which were determined by the Japanese Diabetes Society method, were 0.4 lower than those measured by National Glycohemoglobin Standardization Program methods. 13 Diabetes was defined as HbA1c 6.1%.
14 Dyslipidemia was defined as HDL 40 mg/dl or LDL 140 mg/dl, 15 with triglycerides excluded because not all participants were presumably examined after fasting.
Statistical analysis
Characteristics and prevalence of primary outcomes were described in proportion to total participants, and data were examined within 3, 6 and 12 months of the last relevant checkup. For the characteristics of the baseline data, continuous variables were analyzed with the Wilcoxon-signed rank test, and categorical variables were analyzed with the x 2 test. Sex-specific, age-adjusted logistic regression analysis was performed to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of explanatory variables for lack of follow-up. Sex-specific, logistic multivariate regression analysis, with variables with P , 0.20 in age-adjusted analysis, was also conducted to determine predictors for no clinical follow-up within 6 months of the last relevant checkup. The data regarding drinking habits were substantially missing, and were, therefore, excluded from multivariate analysis. Multiple imputation methods were used to handle missing variables. 16 Two sensitivity analyses were conducted. The first analysis assessed the frequency of no clinical follow-up, at different BP cutoffs of 150/90, 140/100 or 150/100 mmHg. It was on the assumption that health checkup facilities presumably might set hypertension cutoffs .140/90 mmHg as shown in the JHS 2009 guideline, and because clinical follow-up might have been hindered by the belief of the 'regression to the mean' phenomenon. The second sensitivity analysis was performed, on the assumption that all of individuals, who had already been treated for diabetes mellitus or dyslipidemia and were screened to have possible hypertension, visited physicians for their potential hypertension. We assumed that individuals with these underlying diseases would visit the same physicians who also see the co-morbid diseases, but we suspected that ICD-10 codes may not be given unless a specific diagnosis or prescription for hypertension was made. Statistical significance tests were two-sided; P , 0.05 was considered significant. Analyses were performed with Stata, version 11.2 (Stata Corp., College Station, TX, USA).
Results
Participant characteristics
Of the 22 369 individuals screened as possible hypertensives, 17 173 (15 793 males and 1380 females; age ranged 20-68 years old) were eligible for this study (Fig. 1) . Males are younger than females. Females were more likely to have underlying lipid abnormality than males, while no differences were found in the frequency of underlying diabetes mellitus and depressive state. Males were more likely to drink alcohol and to have smoking habits. At the checkup, females have a higher SBP and DBP, respectively. Males had a higher BMI, whereas females had a higher HbA1c. Males were more likely to have proteinuria, and to have high BP pointed out for the first time (Table 1) .
Primary analysis
Among participants, 14 161 males (89.7%) and 1135 females (82.3%) screened as hypertensives did not follow-up 6-month later ( Table 2 ). The proportion remained high 12 months after checkup (86.5% of males and 78.0% of females).
Age-adjusted logistic regression analyses of male participants revealed that lack of clinical follow-up was associated with smoking, underlying diabetes, dyslipidemia and depression, lower HbA1c, lower BMI, incident cases screened as possible hypertensives for the first time, negative proteinuria and lipid abnormality as of the last relevant checkup (Table 3) . No clinical follow-up for possible hypertensives in females was associated with lower BMI, being insured, incident cases and lipid abnormality as of the last relevant checkup (Table 4) . Multivariate regression analyses are also shown in Tables 3 and  4 
Sensitivity analysis
The number of significant predictors decreased as BP cutoffs changed (the first sensitivity analysis). A younger age and lower hypertension category were significant in every analysis for males, while smokers and proteinuria were significant except in only one analysis (Supplementary data, Table S5 ). A younger age was significant in both methods for females, while incident cases and lower BMI was significant in some of the analyses (Supplementary data, Table S5 ).
The second sensitivity analysis described the frequency of no clinical follow-up, on the assumption that all of individuals who had already been treated for diabetes mellitus or dyslipidemia visited physicians for their potential hypertension. Among participants, 13 885 males (87.9%) and 1118 females (81.0%) screened as hypertensives did not follow-up with physicians (Supplementary data, Table S6 ). The predictors of no clinical follow-up for males included a younger age, a lower BMI, a lower HbA1c and positive smoking habits and negative proteinuria. The predictors of no clinical follow-up for females were a younger age, a lower BMI, had a lower BMI, being insured and incident cases of screened as possible hypertension. These results were consistent with the primary analysis.
The prevalence of no clinical follow-up remained high for each sex but tended to decrease as the BP cutoff increased, as described in the primary analysis. Lower BMI and lower HbA1c for males and incident cases in females proved to be independently significant, in addition to the significant predictors shown in primary analysis. Underlying depression independently and significantly predicted no clinical follow-up when the SBP cutoff was 140 mmHg.
Discussion Main finding of this study
This study is the first one to trace working-age adults, identified as possible hypertension during population-based screening. Approximately 80% of study participants between 20 and 68 years of age did not follow-up with physicians within 6 months of a screening where possible hypertension was identified, using 140/90 mmHg as the cutoff. The proportion of no clinical follow-up remained high (.50%) throughout sensitivity analyses where high BP cutoffs, definition of follow-up and follow-up period were assessed in different combinations. Males with milder hypertension, younger age, proteinuria and smoking habits did not follow-up with physicians; younger females were also less likely to follow-up. Lower BMI and lower HbA1c for males and incident cases for females were found to be additional significant predictors. All proportions denote number of relevant. Among 22 369 individuals with possible hypertension, 3293 individuals who had been under antihypertensive treatment were excluded. This excluded population might have received medical checkups and initiated antihypertensive treatment before the study period. Therefore, the present examined population (n ¼ 19 076) might be less-conscious for clinical follow-up than the excluded ones. However, 'population at risk' of our cohort study and research purpose needs to comprise individuals screened as possible hypertension but not concurrently treated.
PREDICTING FAILURE TO FOLLOW-UP SCREENED HIGH BLOOD PRESSURE IN JAPAN
What is already known on this topic
The National Health and Nutrition Survey conducted by the Japanese Ministry of Health, Labour and Welfare recently reported that 69.2% of males and 78.1% of females aged 30 years and screened as hypertensives did not receive antihypertensive treatment. 17 The survey was a self-administered questionnaire, which can be subject to information bias 18 and may have overestimated the prevalence of follow-up.
What this study adds
We had several a priori hypotheses for this study. First, patients with underlying diabetes mellitus or dyslipidemia would tend to visit the same physician who treated these diseases to seek medical advice for possible hypertension. The proportion of non-consultations with physicians remained high in both primary and sensitivity analyses, and thus the underlying medical disorders did not predict the follow-up in this cohort. Second, abnormal checkup data such as proteinuria, high HbA1c and dyslipidemia could motivate participants to seek medical advice, a suggestion not described in previous studies. We found proteinuria, high HbA1c and higher BMI for males and high BMI for females as predictors for clinical follow-up, and thus this hypothesis was confirmed in part. Third, underlying depression might deter participants from visiting physicians because a depressive state predisposes individuals to avoid taking new actions. A cross-sectional survey in Germany suggested that mental disorders could be associated with acknowledged but untreated hypertension. 19 In the present study, underlying depression proved to be a significant predictor of non-consultations only in the sensitivity analysis, which was inconsistent with the primary analysis. Our findings suggest that underlying depression might predict no clinical follow-up consultations in limited situations. According to the 'analytic framework' of the U.S. Preventive Services Task Force, 'How can we most effectively identify patients with hypertension for whom treatment will be beneficial?' is the most relevant question for strategies that bridge screening and treatment of hypertension. 20 To our knowledge, the present study is the first to focus on this issue and clarify predictors of no clinical follow-ups for possible hypertension. Unlike the USA, however, physicians who screen individuals and physicians who treat patients are not always the same in Japan; Japanese individuals screened as possible hypertensives thus need to overcome an additional obstacle to receive treatment. Because screening systems differ across countries, key questions should be established considering their own systems and problems unique to them.
Limitation of this study
This study has some limitations. First, the database lacked information on individual socioeconomic status, such as academic and occupational background. This made it impossible to assess factors that might have potentially affected their health behaviors. Second, the original database included a moderate amount of missing data. Drinking habits, for example, constitute an important facet of lifestyle-related diseases; however, over 20% of such data were missing and thus excluded from multivariate analysis. Other analyses yielded similar results for other variables before and after application of multiple imputation methods (data not shown), implying the robustness of our findings. Third, our cohort excluded individuals over 68 years of age. Further research in elderly population is warranted to assess whether they follow-up with physicians on potential hypertension.
Despite these limitations, our study is the first to trace individuals identified as possible hypertension during populationbased screening in Japan, a unique secondary prevention system against cardiovascular diseases. Continuous emphasis on individuals screened as possible hypertensives, considering the predictors identified by our study, will facilitate follow-up with physicians, improve management of hypertension among the target population, prevent cardiovascular events and eventually reduce related mortality.
Conclusions
In conclusion, approximately 80% of study participants did not follow-up with physicians after identification of possible hypertension in the population-based screening, and the proportion remained consistently high even with higher BP cutoffs. Predictors of no clinical follow-ups included young age, proteinuria, smoking habits and mild hypertension for males and young age for females. To optimize the outcome of a population-based screening system, our findings should be highlighted to trace, enlighten and motivate individuals with possible hypertension.
Supplementary data
Supplementary data are available at the Journal of Public Health online.
